| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/10641963.2015.1089882 |
| P698 | PubMed publication ID | 27018796 |
| P2093 | author name string | Xin Li | |
| Jianjun Mu | |||
| Yanli Shi | |||
| Shujun Yan | |||
| Yingnan Dai | |||
| Jinglu Liu | |||
| Jingxiu Li | |||
| Li Cha | |||
| P2860 | cites work | Endothelium-dependent vasorelaxation to the AMPK activator AICAR is enhanced in aorta from hypertensive rats and is NO and EDCF dependent | Q54639442 |
| Systemic and renal oxidative stress in the pathogenesis of hypertension: modulation of long-term control of arterial blood pressure by resveratrol | Q26999376 | ||
| Endothelial nitric oxide synthase haplotypes are related to blood pressure elevation, but not to resistance to antihypertensive drug therapy | Q28272117 | ||
| Cancer chemopreventive activity of resveratrol, a natural product derived from grapes | Q28300555 | ||
| Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase | Q29615195 | ||
| Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state | Q33968008 | ||
| AMPKalpha2 deletion causes aberrant expression and activation of NAD(P)H oxidase and consequent endothelial dysfunction in vivo: role of 26S proteasomes | Q34059872 | ||
| Tyrosine nitration of PA700 links proteasome activation to endothelial dysfunction in mouse models with cardiovascular risk factors | Q34137316 | ||
| Inhibition of the AMP-activated protein kinase-α2 accentuates agonist-induced vascular smooth muscle contraction and high blood pressure in mice | Q34950411 | ||
| Resveratrol and cancer: chemoprevention, apoptosis, and chemo-immunosensitizing activities | Q35101017 | ||
| Resveratrol prevents the development of choroidal neovascularization by modulating AMP-activated protein kinase in macrophages and other cell types | Q35219152 | ||
| Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I. | Q35540861 | ||
| Resveratrol as an anticancer nutrient: molecular basis, open questions and promises | Q36206828 | ||
| Berberine via suppression of transient receptor potential vanilloid 4 channel improves vascular stiffness in mice | Q36232841 | ||
| Activation of AMP-activated protein kinase α2 by nicotine instigates formation of abdominal aortic aneurysms in mice in vivo | Q36573893 | ||
| Serotonin-induced ion channel modulations in mesenteric artery myocytes from normotensive and DOCA-salt hypertensive rats | Q36919757 | ||
| Suppression of endoplasmic reticulum stress improves endothelium-dependent contractile responses in aorta of the spontaneously hypertensive rat | Q37093720 | ||
| Aberrant endoplasmic reticulum stress in vascular smooth muscle increases vascular contractility and blood pressure in mice deficient of AMP-activated protein kinase-α2 in vivo | Q37125699 | ||
| In vivo activation of AMP-activated protein kinase attenuates diabetes-enhanced degradation of GTP cyclohydrolase I | Q37267054 | ||
| Neurohumoral mechanisms in deoxycorticosterone acetate (DOCA)-salt hypertension in rats | Q37584876 | ||
| Resveratrol in cardiovascular health and disease | Q37831927 | ||
| Perspectives for production and application of resveratrol. | Q37848222 | ||
| Resveratrol in medicinal chemistry: a critical review of its pharmacokinetics, drug-delivery, and membrane interactions. | Q37976865 | ||
| Sirtuin activators and inhibitors | Q38021431 | ||
| Activation of SIRT1 protects pancreatic β-cells against palmitate-induced dysfunction | Q39281003 | ||
| Hydrogen peroxide induces nitric oxide and proteosome activity in endothelial cells: a bell-shaped signaling response | Q42153518 | ||
| Pharmacological activation of AMPK ameliorates perivascular adipose/endothelial dysfunction in a manner interdependent on AMPK and SIRT1. | Q42704533 | ||
| AMP-activated protein kinase mediates the antioxidant effects of resveratrol through regulation of the transcription factor FoxO1. | Q42704686 | ||
| Resveratrol prevents AngII-induced hypertension via AMPK activation and RhoA/ROCK suppression in mice | Q42705046 | ||
| Resveratrol prevents hyperglycemia-induced endothelial dysfunction via activation of adenosine monophosphate-activated protein kinase | Q43295623 | ||
| Mixed messages on blood pressure goals | Q43435847 | ||
| Far-infrared radiation acutely increases nitric oxide production by increasing Ca(2+) mobilization and Ca(2+)/calmodulin-dependent protein kinase II-mediated phosphorylation of endothelial nitric oxide synthase at serine 1179. | Q46139344 | ||
| Na+/H+ exchanger inhibitor prevented endothelial dysfunction induced by high glucose | Q46495977 | ||
| Na+/H+ exchanger is required for hyperglycaemia-induced endothelial dysfunction via calcium-dependent calpain | Q46509665 | ||
| Resveratrol supplementation reduces aortic atherosclerosis and calcification and attenuates loss of aerobic capacity in a mouse model of uremia. | Q46528684 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 287-293 | |
| P577 | publication date | 2016-03-28 | |
| P1433 | published in | Clinical and Experimental Hypertension | Q5133806 |
| P1476 | title | Resveratrol lowers blood pressure in spontaneously hypertensive rats via calcium-dependent endothelial NO production. | |
| P478 | volume | 38 |
| Q55021760 | Biological Activities of Stilbenoids. |
| Q64117183 | Dietary Polyphenols Targeting Arterial Stiffness: Interplay of Contributing Mechanisms and Gut Microbiome-Related Metabolism |
| Q42269581 | Efficacy of resveratrol to supplement oral nifedipine treatment in pregnancy-induced preeclampsia |
| Q58742216 | Endothelial AMP-Activated Kinase α1 Phosphorylates eNOS on Thr495 and Decreases Endothelial NO Formation |
| Q54969589 | Resveratrol Prevents Diabetic Cardiomyopathy by Increasing Nrf2 Expression and Transcriptional Activity. |
Search more.